Organic Process Research & Development 2002, 6, 682−683
An Optimized Process for Formation of 2,4-Disubstituted Imidazoles from
Condensation of Amidines and r-Haloketones
Bryan Li,* Charles K.-F. Chiu, Richard F. Hank, Jerry Murry,† Joshua Roth, and Harry Tobiassen
Pfizer Global Research and DeVelopment, Groton Laboratories, Eastern Point Road, Groton, Connecticut 06340, U.S.A.
Scheme 1
Abstract:
The preparation of 2,4-disubstituted imidazoles from the
condensation of r-haloketones with amidines is described. The
optimal reaction protocol is to add the r-bromoketone solution
to the amidine in aqueous tetrahydrofuran in the presence of
potassium bicarbonate under vigorous reflux. Imidazole was
isolated in 83-91% yield with >95% purity without column
chromatography.
Results and Discussion
Our initial attempts to optimize this reaction focused on
utilizing anhydrous reaction conditions due to stability
concerns of R-bromoketones under basic aqueous conditions.
Condensations using a variety of bases (potassium tert-
butoxide, potassium carbonate, cesium carbonate, etc.) in
THF, DMF, CH3CN, or CH2Cl2 gave low yields. Reactions
in alcohols (ethanol, 2-propanol, and tert-butyl alcohol) were
also unsatisfactory. We then investigated mixed organic/
aqueous reaction media, as we reasoned that amidines are
stronger nucleophiles than water, and therefore the condensa-
tion rate of R-bromoketones with amidines should be faster
than the decomposition rate of the bromoketone in water. A
series of reactions using THF, DMF, or alcohols as the
organic solvent were conducted, and from these experiments
we made a number of observations.
(1) Aqueous THF is a suitable media to bring the very
polar amidines and nonpolar R-bromoketones in the same
phase, and it is superior to aqueous DMF or alcohol.
(2) Higher reaction temperatures in aqueous THF ac-
celerates the condensation.
(3) Bicarbonate is the base of choice, as it only serves to
scavenge the acid produced during the condensation reaction.
(4) As R-bromoketones decompose under the reaction
conditions, their concentrations in the reaction should be
minimized.
Introduction
The imidazole nucleus is often found in biologically active
molecules,1 and a large variety of methods have been
employed for their synthesis.2 We recently had a need to
develop a more viable process for the preparation of
multikilogram quantities of 2,4-disubstituted imidazoles. The
condensation of amidines, which are readily accessible from
nitriles,3 with R-haloketones has become a widely used
method for the synthesis of 2,4-disubstituted imidazoles
(Scheme 1). A literature survey showed that chloroform was
the most commonly used solvent for this reaction.4 In
addition to the use of a nonbenign solvent, yields of the
reaction varied from poor to moderate, and column chro-
matography was often needed for product isolation. Use of
other solvents such as alcohols,5 DMF,6 and acetonitrile7 have
also been reported for this reaction, but yields are also
frequently poor.
* To whom correspondence should be addressed. Fax: (860) 715-7305.
E-mail: bryan_li@groton.pfizer.com.
† Current Address: Process Research Department, Merck Research Labora-
tories, Merck and Co. Inc., Rahway, NJ, U.S.A.
(1) Kudzma, L. V.; Turnbull, S. P.,Jr. Synthesis 1991, 1021. (b) Compagnone,
R. S.; Rapport, H. J. Org. Chem. 1986, 51, 1713 and references therein.
(c) Shapiro, S.; Enz, A. Drugs Future 1992, 17, 489.
(2) For examples, see: (a) Grimmett, M. R. In ComprehensiVe Heterocycle
Chemistry; Katritzky, A. R., Rees, C., Eds.; Pergamon Press: Elmsford,
NY, 1984; Vol. 5 and references therein. (b) Grimmet, M. R. In
ComprehensiVe Heterocycle Chemistry II; Katritzky, A. R., Rees, C.,
Scriven, E. F. V., Eds.; Pergamon Press: Elmsford, NY, 1996; Vol. 3, and
references therein. (c) Varma, R. S.; Kumar, D. Tetrahedron Lett. 1999,
40, 7665. (d) Heras, M.; Ventura, M.; Linden, A.; Villalgordo, J. M.
Synthesis 1999, 9, 1613. (e) Lengeler, D.; Weisz, K. Nucleosides Nucleotides
1999, 18, 1657. (f) Batanero, B.; Escudero, J.; Barba, F. Org. Lett. 1999,
1, 1521. (g) Bergemann, M.; Neidlein, R. HelV. Chim. Acta 1999, 82, 909.
(3) (a) Boere, R. T.; Oakley, T. T.; Reed, R. W. J. Organomet. Chem. 1987,
331, 161. (b) Thurkauf, A.; Hutchison, A.; Peterson, J.; Cornfield, L.;
Meade, R. J. Med. Chem. 1995, 38, 2251.
(4) (a) Kempter, G.; Spindler, J.; Fiebig, H. J.; Sarodnick, G. J. Prakt. Chem.
1971, 313, 977. (b) Baldwin, J. J.; Christy, M. E.; Denny, G. H.; Habecker,
C. N.; Freedman, M. B. J. Med. Chem. 1986, 29, 1065. (c) Nagao, Y.;
Takahashi, K.; Torisu, K.; Kondo, K.; Hamanaka, N. Heterocycles 1996,
42, 517. (d) Baldwin, J. J.; Engelhardt, E. L.; Hirschmann, R.; Lundell, G.
F.; Ponticello, G. S. J. Med. Chem. 1979, 22, 687.
We found that the optimal reaction protocol was to add
a solution of R-bromoketone in THF to the amidine in
aqueous THF in the presence of potassium bicarbonate under
vigorous reflux. Once the reaction was complete, the THF
was removed, and the product crystallized directly out of
the remaining solvent. Using this protocol, 2,4-disubstituted
(6) Kikuchi, K.; Hibi, S.; Yoshimura, H.; Tokuhara, N.; Tai, K.; Hida, T.;
Yamauchi, T.; Nagai, M. J. Med. Chem. 2000, 43, 409.
(7) Moody, C. J.; Roffey, J. R. A. Chem. Abstr. 2000, 134, 71748.
(8) Burtles, P. J. Chem. Soc. 1923, 123, 362.
(9) Lombardino, J. G.; Wiseman, E. H. J. Med. Chem. 1974, 17, 1182.
(10) Baldwin, J. J.; Lumma, P. K.; Novello, F. C.; Ponticello, G. S.; Sprague,
J. M.; Duggan, D. E. J. Med. Chem. 1977, 20, 1189.
(11) Baldwin, J. J.; Engelhardt, E. L.; Hirschmann, R.; Lundell, G. S.; Ponticello,
G. S. J. Med. Chem. 1979, 22, 687.
(5) Baldwin, J. E.; Fryer, A. M.; Pritchard, G. J. J. Org. Chem. 2001, 66, 2588.
(12) Nakanish, S.; Nantaku, J.; Otsuji, Y. Chem. Lett. 1983, 3, 341.
682
•
Vol. 6, No. 5, 2002 / Organic Process Research & Development
10.1021/op025552b CCC: $22.00 © 2002 American Chemical Society
Published on Web 07/23/2002